Compare NC & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NC | CYRX |
|---|---|---|
| Founded | 1913 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Coal Mining | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 374.1M | 419.3M |
| IPO Year | 2006 | 2008 |
| Metric | NC | CYRX |
|---|---|---|
| Price | $51.00 | $9.96 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $12.94 |
| AVG Volume (30 Days) | 7.3K | ★ 406.1K |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.99% | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | ★ 2.35 | 1.40 |
| Revenue | $104,778,000.00 | ★ $176,177,000.00 |
| Revenue This Year | N/A | $11.06 |
| Revenue Next Year | N/A | $8.45 |
| P/E Ratio | $21.58 | ★ $6.89 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $32.16 | $5.21 |
| 52 Week High | $59.42 | $11.45 |
| Indicator | NC | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 43.68 | 70.69 |
| Support Level | $47.39 | $9.18 |
| Resistance Level | $50.47 | $10.23 |
| Average True Range (ATR) | 1.72 | 0.42 |
| MACD | 0.00 | 0.19 |
| Stochastic Oscillator | 11.90 | 88.01 |
NACCO Industries Inc is a holding company that operates in the mining and natural resource industries. It has three operating segments: Utility Coal Mining, Contract Mining, and Minerals and Royalties. The Utility Coal Mining segment, operated by North American Coal, manages surface coal mines that are exclusive, long-term fuel providers for power generation companies. The Contract Mining segment, operated by North American Mining, is a provider of a broad range of specialized, long-term contract mining services. The Minerals and Royalties segment, which includes the Catapult Mineral Partners (Catapult) business, acquires and promotes the development of mineral and royalty interests and other related investments.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.